Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions

被引:49
作者
Rudolph, P
Schubert, C
Schubert, B
Parwaresch, R
机构
[1] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT PATHOL,D-2300 KIEL,GERMANY
[2] INST DERMATOPATHOL,BUCHHOLZ,GERMANY
[3] DEPT DERMATOL,BUXTEHUDE,GERMANY
关键词
D O I
10.1016/S0190-9622(97)80121-1
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: A discrimination between benign and malignant melanocytic lesions is not always possible by conventional histology. Objective: Our purpose was to determine the proliferative activity in various types of melanocytic neoplasms and to appraise its value as a diagnostic adjunct. Methods: The growth fraction was assessed immunohistochemically in 398 melanocytic lesions by means of the monoclonal antibody Ki-SS directed to the Ki-67 antigen. In this way, a cut-off level was defined and applied to 112 lesions of equivocal histology. The revised diagnoses were correlated to the clinical courses. Results: Common nevi, Spitz nevi, and melanomas exhibited significantly different proliferation indices and distinctive distribution patterns of cycling cells. In agreement, malignancy diagnosed on the basis of a growth fraction greater than 5% was confirmed by disease progression in 68% of our cases with uncertain diagnosis. Conclusion: Determination of the proliferative activity in melanocytic lesions may usefully complement conventional histology to improve diagnostic accuracy.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 38 条
[1]  
ACKERMAN AB, 1984, LIVES LESIONS, P231
[2]  
Ackerman AB., 1994, PITFALLS HISTOPATHOL
[3]  
BARNHILL RL, 1993, AM J PATHOL, V143, P99
[4]   PLEXIFORM SPINDLE CELL NEVUS - A DISTINCTIVE VARIANT OF PLEXIFORM MELANOCYTIC NEVUS [J].
BARNHILL, RL ;
MIHM, MC ;
MAGRO, CM .
HISTOPATHOLOGY, 1991, 18 (03) :243-247
[5]  
BARNHILL RL, 1994, PATHOLOGY MELANOCYTI
[6]   The pattern of HMB-45 antibody staining in compound Spitz nevi [J].
Bergman, R ;
Dromi, R ;
Trau, H ;
Cohen, I ;
Lichtig, C .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1995, 17 (06) :542-546
[7]   MODEL PREDICTING SURVIVAL IN STAGE-I MELANOMA BASED ON TUMOR PROGRESSION [J].
CLARK, WH ;
ELDER, DE ;
GUERRY, D ;
BRAITMAN, LE ;
TROCK, BJ ;
SCHULTZ, D ;
SYNNESTVEDT, M ;
HALPERN, AC .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24) :1893-1904
[8]   A STUDY OF TUMOR PROGRESSION - THE PRECURSOR LESIONS OF SUPERFICIAL SPREADING AND NODULAR MELANOMA [J].
CLARK, WH ;
ELDER, DE ;
GUERRY, D ;
EPSTEIN, MN ;
GREENE, MH ;
VANHORN, M .
HUMAN PATHOLOGY, 1984, 15 (12) :1147-1165
[9]   The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel [J].
Cook, MG ;
Clarke, TJ ;
Humphreys, S ;
Fletcher, A ;
McLaren, KM ;
Smith, NP ;
Stevens, A ;
Theaker, JM ;
Melia, J .
HISTOPATHOLOGY, 1996, 28 (06) :497-512
[10]  
ELDER DE, 1991, MELANCYTIC TUMORS SK